SNP,effect_allele.exposure,other_allele.exposure,effect_allele.outcome,other_allele.outcome,beta.exposure,beta.outcome,eaf.exposure,eaf.outcome,remove,palindromic,ambiguous,id.outcome,chr,pos,se.outcome,samplesize.outcome,pval.outcome,outcome,mr_keep.outcome,se.exposure,samplesize.exposure,chr.exposure,pos.exposure,pval.exposure,id.exposure,exposure,mr_keep.exposure,pval_origin.exposure,data_source.exposure,action,mr_keep
rs1008878,T,G,T,G,0.000629328,0.038,0.567102,0.576541,FALSE,FALSE,FALSE,ebi-a-GCST002245,9,22036112,0.0157,54162,0.01547,Alzheimer's disease (late onset),TRUE,0.00010987,462933,9,22036112,1e-08,ukb-b-17616,Treatment/medication code: xalatan 0.005% eye drops || id:ukb-b-17616,TRUE,reported,igd,2,TRUE
rs1254276,T,C,T,C,0.000663267,-0.0152,0.390234,0.402584,FALSE,FALSE,FALSE,ebi-a-GCST002245,14,60847001,0.0158,54162,0.3366,Alzheimer's disease (late onset),TRUE,0.000111715,462933,14,60847001,2.90001e-09,ukb-b-17616,Treatment/medication code: xalatan 0.005% eye drops || id:ukb-b-17616,TRUE,reported,igd,2,TRUE
rs2472493,A,G,A,G,-0.000608217,-0.0054,0.557934,0.581511,FALSE,FALSE,FALSE,ebi-a-GCST002245,9,107695848,0.0155,54162,0.7266,Alzheimer's disease (late onset),TRUE,0.000110655,462933,9,107695848,3.89996e-08,ukb-b-17616,Treatment/medication code: xalatan 0.005% eye drops || id:ukb-b-17616,TRUE,reported,igd,2,TRUE
rs28715921,C,T,C,T,-0.000714352,-0.0077,0.59814,0.596421,FALSE,FALSE,FALSE,ebi-a-GCST002245,4,7887974,0.0158,54162,0.6251,Alzheimer's disease (late onset),TRUE,0.000111207,462933,4,7887974,1.29999e-10,ukb-b-17616,Treatment/medication code: xalatan 0.005% eye drops || id:ukb-b-17616,TRUE,reported,igd,2,TRUE
rs9913911,G,A,G,A,-0.000635135,0.0176,0.376303,0.372763,FALSE,FALSE,FALSE,ebi-a-GCST002245,17,10031183,0.0168,54162,0.2965,Alzheimer's disease (late onset),TRUE,0.00011285,462933,17,10031183,1.79999e-08,ukb-b-17616,Treatment/medication code: xalatan 0.005% eye drops || id:ukb-b-17616,TRUE,reported,igd,2,TRUE
